- 2016
- Press releases - 29.03.2016
Dassault Systèmes and Inserm Announce Joint Agreement to Decipher Disease Complexity and Accelerate Clinical Research
Next Generation Scientific Innovation with the 3DEXPERIENCE Platform and Strategic Collaboration to Advance Programs in Aging, Cancer, Genomics and Microbiota
- Press releases - 24.03.2016
Isolated case of bovine spongiform encephalopathy (BSE) in France
This Thursday, 24 March, the Ministry of Agriculture confirmed an isolated case of bovine spongiform encephalopathy (BSE), or mad cow disease, at a farm in Ardennes. The case was detected in a 5-year-old cow sent for rendering, “a method for processing animals that die on farms, and are therefore not intended for human consumption,” states AFP. In France, the last case of bovine spongiform encephalopathy dates back to 2011.
- What's on? - 24.03.2016
Isolated case of bovine spongiform encephalopathy (BSE) in France
This Thursday, 24 March, the Ministry of Agriculture confirmed an isolated case of bovine spongiform encephalopathy (BSE), or mad cow disease, at a farm in Ardennes. The case was detected in a 5-year-old cow sent for rendering, “a method for processing animals that die on farms, and are therefore not intended for human consumption,” states […]
- Press releases - 23.03.2016
A study demonstrates the possibility of changing the behaviour of the gaze by transcranial magnetic stimulation
A study financed by the Assistance Publique-Hôpitaux de Paris[1] has been conducted under the direction of Monica Zilbovicius[2] in the Inserm Unit 1000 on a particular region of the brain, the superior temporal sulcus (STS), influencing perception and behaviour of the gaze. This work has shown that transcranial magnetic stimulation (non-invasive and painless) of the STS can selectively and transiently inhibit the subject’s gaze into the eyes of the person speaking to them. Published in the journal Cerebral Cortex, it offers new therapeutic prospects for autistic patients precisely presenting anatomical and functional differences of the superior temporal sulcus.
- Press releases - 21.03.2016
Cycle « Santé en questions » citizen conferences: the next meetings
Since 2012, to promote dialogue between science and society, Inserm and Universcience has offered « Santé en questions », an annual cycle of citizen conferences. The aim is to provide information about advances in life sciences and healthcare research, but also to allow the public to tell their story and talk to the speakers. These conferences are chaired by a journalist and held by link up between the Cité des Sciences et de l’Industrie in Paris and a regional partner site. The filmed conferences are available on the Internet and summarised in a booklet sent to politicians and distributed with the latest edition of the French magazine La Recherche.
- Press releases - 17.03.2016
Discovery of a gene associated with radiosensitivity and post-radiotherapy complications
Scientists at the CEA’s Institute of Cellular and Molecular Radiation Biology, in collaboration with INSERM, Université Paris-Sud, and international partners, have demonstrated a connection between the expression of the TRAIL gene, which plays a role in cell death, and the radiosensitivity of certain human T lymphocytes. This research also showed a relationship between three genetic forms of TRAIL and the radiosensitivity of these T lymphocytes. Finally, two of these genetic forms of TRAIL were linked with serious skin complications in breast cancer patients treated with radiotherapy. These results, published on the Oncotarget website on 16th March 2016, indicate how determining the radiosensitivity of lymphocytes and studying the gene polymorphisms associated with this radiosensitivity could lead to personalised radiotherapy.
- Press releases - 11.03.2016
Reuters Ranking: CEA, CNRS and Inserm in the Top 10 worldwide research institutions for innovation
The ranking compiled by Thomson Reuters covers the “25 public institutions that contribute most to scientific and technological advancement worldwide” according to Reuters. The CEA is topping the list of worldwide organisations, with CNRS in 5th place and Inserm in 10th place.
- Press releases - 09.03.2016
Brain Awareness Week 2016: 14–20 March
The 17th edition of Brain Awareness Week will take place from 14 to 20 March 2016, in 62 countries as well as France. During this week, the general public is invited to come and meet researchers in order to better understand the workings of the brain and to find out about advances in research.
- What's on? - 09.03.2016
Brain Awareness Week 2016: 14–20 March
The 17th edition of Brain Awareness Week will take place from 14 to 20 March 2016, in 62 countries as well as France. During this week, the general public is invited to come and meet researchers in order to better understand the workings of the brain and to find out about advances in research. Researchers […]
- Press releases - 09.03.2016
Towards better understanding of the side effects of radiotherapy
Two studies, one theoretical and the other biological and clinical, conducted by Nicolas Foray, radiobiologist at the Combined Research Unit 1052 ‘Cancer Research Centre of Lyon’ (Inserm/CNRS/Centre Léon-Bérard/Lyon I University), have just been published in the International Journal of Radiation Biology and the International Journal of Radiation Oncology. These two studies allow a better understanding of the adverse side effects of radiotherapy. They propose a new theory about the cellular response to ionising radiation. This theory is based on having revealed a protein called ATM passing from the cytoplasm to the nucleus of irradiated cells. Once inside the nucleus, the ATM protein initiates repair of breaks in the DNA: the longer this transit is delayed, the greater the radio-sensitivity of the cells and the more marked the adverse side effects of the radiotherapy.